Literature DB >> 20606041

No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women.

Erin M Siegel1, Jason L Salemi, Neal E Craft, Luisa L Villa, Alex S Ferenczy, Eduardo L Franco, Anna R Giuliano.   

Abstract

Although oncogenic human papillomavirus (HPV) infections have been established as the necessary cause of cervical cancer, most HPV infections are transient and rarely progress to squamous cervical lesions. The activity of HPV is tightly associated with epithelial cell differentiation; therefore, regulators of differentiation, such as retinoic acid (RA), have been considered targets for the prevention of HPV-associated squamous intraepithelial lesion (SIL) development. The purpose of this study was to determine the association between circulating RA and early events in cervical carcinogenesis, specifically type-specific HPV clearance and SIL detection. Archived blood samples from 643 women participating in the Ludwig-McGill Cohort in São Paulo, Brazil, were analyzed by high-pressure liquid chromatography for three RA isomers (all-trans, 13-cis, and 9-cis-RA). A type-specific HPV clearance event was defined as two consecutive visits negative for an HPV type during follow-up for 364 HPV-positive women. Among the 643 women in this analysis, 78 were diagnosed with incident SIL. The probability of clearing an oncogenic HPV infection was not significantly different across RA isomer quartiles. There was a suggestion that increasing all-trans-RA increased the rate of nononcogenic HPV clearance (P-trend = 0.05). There was no association observed between serum RA levels and incident SIL. Our results suggest that elevated circulating RA isomer levels do not increase the rate of HPV clearance or reduce the risk of incident SIL. The role of RA in the inhibition of HPV-induced carcinogenesis, as shown in vitro, lacks confirmatory evidence within epidemiologic studies among women. 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606041      PMCID: PMC2917513          DOI: 10.1158/1940-6207.CAPR-09-0239

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  40 in total

1.  13-cis-retinoic acid for chemoprevention after colpoconization for cervical intraepithelial neoplasia.

Authors:  S H Kim; T K Park; J Y Kwon
Journal:  Int J Gynaecol Obstet       Date:  2003-05       Impact factor: 3.561

2.  Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III.

Authors:  Mack T Ruffin; Joanne M Bailey; Daniel P Normolle; Claire W Michael; Mary E Bieniasz; David C Kmak; Elizabeth R Unger; Dean E Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

3.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 4.  Interactions of retinoid binding proteins and enzymes in retinoid metabolism.

Authors:  J L Napoli
Journal:  Biochim Biophys Acta       Date:  1999-09-22

Review 5.  Mechanisms used by human papillomaviruses to escape the host immune response.

Authors:  Shreya Kanodia; Laura M Fahey; W Martin Kast
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

Review 6.  Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.

Authors:  Jafaru Abu; Madu Batuwangala; Karl Herbert; Paul Symonds
Journal:  Lancet Oncol       Date:  2005-09       Impact factor: 41.316

Review 7.  New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.

Authors:  M von Knebel Doeberitz
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

8.  The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.

Authors:  M T Goodman; N Kiviat; K McDuffie; J H Hankin; B Hernandez; L R Wilkens; A Franke; J Kuypers; L N Kolonel; J Nakamura; G Ing; B Branch; C C Bertram; L Kamemoto; S Sharma; J Killeen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-06       Impact factor: 4.254

9.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.

Authors:  F L Meyskens; E Surwit; T E Moon; J M Childers; J R Davis; R T Dorr; C S Johnson; D S Alberts
Journal:  J Natl Cancer Inst       Date:  1994-04-06       Impact factor: 13.506

View more
  2 in total

1.  Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?

Authors:  Erin M Siegel; Nitin Patel; Beibei Lu; Ji-Hyun Lee; Alan G Nyitray; Neal E Craft; Krystyna Frenkel; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Int J Cancer       Date:  2011-11-28       Impact factor: 7.396

2.  In vitro inhibition of mumps virus by retinoids.

Authors:  Kaitlin J Soye; Claire Trottier; Thomas Z Di Lenardo; Katherine H Restori; Lee Reichman; Wilson H Miller; Brian J Ward
Journal:  Virol J       Date:  2013-11-14       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.